The FDA OKs Pfizer-BioNTech Booster For People 65+ Or At High Risk For Severe COVID
The Food and Drug Administration authorized a booster dose Wednesday of the Pfizer-BioNTech COVID-19 vaccine for people 65 and older and others at high risk of severe COVID-19. The…